You are here: Industry Insights > Vaccine

News List

Targeted Interventions Raise HPV Vaccine Acceptance in Women drugs
July 26, 2019
Among young women, targeted educational interventions, particularly educational videos...
Yisheng Biopharma receives approval from China NMPA for rabies vaccine production facility biospectrumasia
July 23, 2019
The vaccine has demonstrated effective protection, contributing to the fight against rabies infection.
China set to begin Phase II HIV vaccine trials europeanpharmaceuticalreview
July 23, 2019
A vaccine containing the DNA of HIV is poised to enter a Phase II trial, making it the first vaccine of its kind to do so.
Recommendations Developed for Japanese Encephalitis Vaccine drugs
July 22, 2019
In the?issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report...
DRC rejects clinical trial for experimental Ebola vaccine europeanpharmaceuticalreview
July 19, 2019
The?health?minister?for?the?Democratic?Republic?of?the?Congo?has?stated?an?experimental?Ebola?vaccine?will?not?be?trialled?in?the?country.
Educational Handout May Increase Receipt of Child Flu Shot drugs
July 17, 2019
Providing an educational handout about influenza disease in the waiting room before a pediatric provider visit may increase receipt of child influenza vaccine...
First Patient Dosed with DNA-based, Neoantigen-Targeting Personalized Vaccine from Geneos americanpharmaceuticalreview
July 12, 2019
Geneos Therapeutics, a clinical-stage biotech company, a spin-out of Inovio Pharmaceuticals, announced the first cancer patient was dosed using the company's GT-EPIC Neoantigen-Targeting Personalized Vaccine Technology.
Flu Vaccine Safe During Pregnancy drugs
July 12, 2019
Pregnant women can take comfort in new findings that suggest?flu?vaccines won't harm their fetuses.
First Participant Enrolled in Second Phase 3 Universal Flu Vaccine Trial americanpharmaceuticalreview
July 09, 2019
BiondVax Pharmaceuticals announced the first participants in the second cohort of the pivotal, clinical efficacy, Phase 3 trial of the M-001 universal flu vaccine candidate have been successfully enrolled.
45 Percent of U.S. Adults Have Some Doubts About Vaccine Safety drugs
July 09, 2019
Just under half of U.S. adults have some doubts about vaccine safety, according to a survey released by the American Osteopathic Association.